Company profilePharmaceutical#62 of 1,318 in Pakistan✓ No DRAP alerts

MEDISAVE PHARMACEUTICALS

Pharmaceutical company · 221 brands · 209 molecules

Ranked #52 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

221 registered products 59 pharmaceutical brands 209 distinct molecules 0 DRAP alerts

Company overview

221
registered products
59
pharmaceutical brands
209
distinct molecules
12
therapeutic classes
0
DRAP alerts

MEDISAVE PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 221 product registrations across 209 distinct molecules. It is the 62nd largest registrant in Pakistan by product count, and ranks 52nd of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antiinflammatory And Antirheumatic Products. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by MEDISAVE

120 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

117
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20252
2026115

Top molecules by brand count

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 6Antiinflammatory And Antirheumatic Products · 6Quinolone Antibacterials · 6Other Beta-Lactam, Cephalosporins & Penems · 5Antiemetics & Antinauseants · 4Macrolides, Lincosamides And Streptogramins · 4Antivirals For Systemic Use · 3Antianemic, Iron Preparations · 3Blood Conditions · 2Antiepileptics · 2Drugs For Treatment Of Bone Diseases · 2Antidepressants · 2

Conditions treated

Anaemia · 2General Infections · 1Pain Killers · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official216 products · Rs 5.55 – Rs 29,423.22
DVAGO2 products · Rs 152 – Rs 218.5
Servaid6 products · Rs 80.5 – Rs 1,150
Median across source: Rs 251.4

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 230 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
BIO LABS (PVT) LTD. holds 103 molecules not in this portfolio
000 I.UAprepitantAremetherArtesunateAtorvastatinAzathioprine
NEUTRO PHARMA (PVT) LTD. holds 91 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAnastrazoleAnastrozoleAntimony

Get the full profile for MEDISAVE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.